Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Memantine 5mg/10mg/15mg/20mg tablets treatment initiation pack |
BNF code | 0411000G0AAAEAE |
Virtual Therapeutic Moiety | Memantine |
Abbreviated name | Memantine 5mg/10mg/15mg/20mg tabs treatment initiation pack |
Basis of preferred name | Other |
Date of name applicability | 4 Apr 2018 |
Previous name | Generic Ebixa tablets treatment initiation pack |
Basis of previous name | Other |
Combination product | Combination Product |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Not applicable |
Dose Form | |
---|---|
Formulation | Not applicable |
Drug Route | |
Route | Route of administration not applicable |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Actual Medicinal Products | |
Ebixa tablets treatment initiation pack (Lundbeck Ltd) | |
Memantine 5mg/10mg/15mg/20mg tablets treatment initiation pack (A A H Pharmaceuticals Ltd) | |
Memantine 5mg/10mg/15mg/20mg tablets treatment initiation pack (Lupin Healthcare (UK) Ltd) | |
Memantine 5mg/10mg/15mg/20mg tablets treatment initiation pack (Medihealth (Northern) Ltd) | |
Virtual Medicinal Product Packs | |
Memantine 5mg/10mg/15mg/20mg tablets treatment initiation pack 28 tablet |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.